These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 10877451)

  • 41. Possible activation of the NO-cyclic GMP-protein kinase G-K+ channels pathway by gabapentin on the formalin test.
    Ortiz MI; Medina-Tato DA; Sarmiento-Heredia D; Palma-Martínez J; Granados-Soto V
    Pharmacol Biochem Behav; 2006 Mar; 83(3):420-7. PubMed ID: 16630650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats.
    McDonald CE; Gagnon MJ; Ellenberger EA; Hodges BL; Ream JK; Tousman SA; Quock RM
    J Pharmacol Exp Ther; 1994 May; 269(2):601-8. PubMed ID: 8182526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The dual effect of a nitric oxide donor in nociception.
    Sousa AM; Prado WA
    Brain Res; 2001 Apr; 897(1-2):9-19. PubMed ID: 11282353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the NO/cGMP/K(ATP) pathway in the protective effects of sildenafil against ethanol-induced gastric damage in rats.
    Medeiros JV; Gadelha GG; Lima SJ; Garcia JA; Soares PM; Santos AA; Brito GA; Ribeiro RA; Souza MH
    Br J Pharmacol; 2008 Feb; 153(4):721-7. PubMed ID: 18071300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Nitric oxide/CGMP/KATP pathway mediates systemic and central antinociception induced by resistance exercise in rats.
    Galdino GS; Xavier CH; Almeida R; Silva G; Fontes MA; Menezes G; Duarte ID; Perez AC
    Int J Neurosci; 2015; 125(10):765-73. PubMed ID: 25271801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and Nomega(6)-nitro-L-arginine methyl ester (NAME) on cyclic GMP levels during muscarinic activation of tracheal smooth muscle.
    Guerra de González L; Misle A; Pacheco G; Napoleón de Herrera V; González de Alfonzo R; Lippo de Bécemberg I; Alfonzo MJ
    Biochem Pharmacol; 1999 Aug; 58(4):563-9. PubMed ID: 10413293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-hydroxytryptamine- and U46619-mediated vasoconstriction in bovine pulmonary conventional and supernumerary arteries: effect of endogenous nitric oxide.
    Bunton D; MacDonald A; Brown T; Tracey A; McGrath JC; Shaw AM
    Clin Sci (Lond); 2000 Jan; 98(1):81-9. PubMed ID: 10600662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on the antinociceptive effects of sodium nitroprusside and molsidomine in mice.
    Fidecka S; Lalewicz S
    Pol J Pharmacol; 1997; 49(6):395-400. PubMed ID: 9566042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular base of acetylcholine and morphine analgesia.
    Ferreira SH; Duarte ID; Lorenzetti BB
    Agents Actions Suppl; 1991; 32():101-6. PubMed ID: 1676874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
    Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
    J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tonic inhibitory action by nitric oxide on spontaneous mechanical activity in rat proximal colon: involvement of cyclic GMP and apamin-sensitive K+ channels.
    Mulè F; D'Angelo S; Serio R
    Br J Pharmacol; 1999 May; 127(2):514-20. PubMed ID: 10385253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noradrenaline activates the NO/cGMP/ATP-sensitive K(+) channels pathway to induce peripheral antinociception in rats.
    Romero TR; Guzzo LS; Perez AC; Klein A; Duarte ID
    Nitric Oxide; 2012 Mar; 26(3):157-61. PubMed ID: 22330728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nitric oxide signaling in pain and nociceptor sensitization in the rat.
    Aley KO; McCarter G; Levine JD
    J Neurosci; 1998 Sep; 18(17):7008-14. PubMed ID: 9712669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. L-arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway.
    Kawabata A; Umeda N; Takagi H
    Br J Pharmacol; 1993 May; 109(1):73-9. PubMed ID: 8388303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nitric oxide modulates cardiac performance in the heart of Anguilla anguilla.
    Imbrogno S; De Iuri L; Mazza R; Tota B
    J Exp Biol; 2001 May; 204(Pt 10):1719-27. PubMed ID: 11316492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of L-arginine on the afferent resting activity in the cephalopod statocyst.
    Tu Y; Budelmann BU
    Brain Res; 1999 Oct; 845(1):35-49. PubMed ID: 10529442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
    Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
    Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of l-arginine/SNAP/NO/cGMP/K
    Safaripour S; Nemati Y; Parvardeh S; Ghafghazi S; Fouladzadeh A; Moghimi M
    J Pharm Pharmacol; 2018 Apr; 70(4):507-515. PubMed ID: 29380385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Participation of the GABA/benzodiazepine receptor and the NO-cyclicGMP pathway in the "antinociceptive-like effects" of diazepam.
    Jiménez-Velázquez G; López-Muñoz FJ; Fernández-Guasti A
    Pharmacol Biochem Behav; 2008 Nov; 91(1):128-33. PubMed ID: 18638499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulatory effect of cyclooxygenase inhibitors on sildenafil-induced antinociception.
    Patil CS; Jain NK; Singh A; Kulkarni SK
    Pharmacology; 2003 Dec; 69(4):183-9. PubMed ID: 14624058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.